[Federal Register Volume 82, Number 177 (Thursday, September 14, 2017)]
[Notices]
[Pages 43237-43238]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-19497]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Immunization Practices
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
[[Page 43238]]
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with section 10(a)(2) of the Federal Advisory
Committee Act, the Centers for Disease Control and Prevention (CDC)
announces the following meeting of the Advisory Committee on
Immunization Practices (ACIP).
This meeting is open to the public, limited only by the space
available. Time will be available for public comment. The public is
welcome to submit written comments in advance of the meeting. Comments
should be submitted in writing by email to the contact person listed
below. The deadline for receipt is October 11, 2017. Written comments
must include full name, address, organizational affiliation, email
address of the speaker, topic being addressed and specific comments.
Written comments must not exceed one single-spaced typed page with 1-
inch margins containing all items above. Only those written comments
received 10 business days in advance of the meeting will be included in
the official record of the meeting. Public comments made in attendance
must be no longer than 3 minutes and the person giving comments must
attend the public comment session at the start time listed on the
agenda. Time for public comments may start before the time indicated on
the agenda. The meeting will be webcast live via the World Wide Web;
for instructions and more information on ACIP please visit the ACIP Web
site: http://www.cdc.gov/vaccines/acip/index.html.
DATES: The meeting will be held on October 25, 2017, 8:00 a.m. to 6:00
p.m., EDT, and October 26, 2017 8:00 a.m. to 3:15 p.m. EDT.
ADDRESSES: 1600 Clifton Road NE., Atlanta, GA 30329, CDC, Tom Harkin
Global Communications Center, Kent `Oz' Nelson Auditorium.
FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee
Management Specialist, CDC, NCIRD; email: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The committee is charged with advising the Director, CDC,
on the use of immunizing agents. In addition, under 42 U.S.C. 1396s,
the committee is mandated to establish and periodically review and, as
appropriate, revise the list of vaccines for administration to vaccine-
eligible children through the Vaccines for Children (VFC) program,
along with schedules regarding dosing interval, dosage, and
contraindications to administration of vaccines. Further, under
provisions of the Affordable Care Act, section 2713 of the Public
Health Service Act, immunization recommendations of the ACIP that have
been approved by the Director of the Centers for Disease Control and
Prevention and appear on CDC immunization schedules must be covered by
applicable health plans.
Matters to be Considered: The agenda will include discussions on
adult immunization schedule, child/adolescent immunization schedule,
influenza vaccines, anthrax vaccine, Japanese encephalitis vaccines,
hepatitis vaccines, herpes zoster vaccines, human papillomavirus
vaccines, mumps vaccine, pneumococcal vaccines, respiratory syncytial
virus vaccine and immunization safety update. A recommendation vote is
scheduled for adult immunization schedule, child/adolescent
immunization schedule, hepatitis vaccines and herpes zoster vaccines. A
Vaccines for Children vote is scheduled for hepatitis vaccines. Agenda
items are subject to change as priorities dictate.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2017-19497 Filed 9-13-17; 8:45 am]
BILLING CODE 4163-18-P